Stephen Tullman Net Worth & Insider Trades

Stephen Tullman - Director, Aclaris Therapeutics, Inc

As of October 5, 2018

What is Stephen Tullman's Net Worth?

The current estimated net worth of Aclaris Therapeutics, Inc's Director, Stephen Tullman, is estimated to be about $2.71M . Stephen Tullman owns about 571,471 units of Aclaris Therapeutics, Inc common stock. In the last 3 years at Aclaris Therapeutics, Inc, Stephen Tullman has sold an estimated value of $0 worth.

What is Stephen Tullman's Past Insider Trading?

Stephen Tullman's largest purchase order was 26,700 units , worth over $441.62K on April 9, 2018. In total, Stephen Tullman has made about 8 transactions over 3 years of their time at Aclaris Therapeutics, Inc. Stephen Tullman usually trades in October and August, with the busiest year in 2018. The most recent transaction was a purchase order of 7,100 units , worth over $99.37K on October 5, 2018.

Stephen Tullman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Stephen Tullman's' Mailing Address?

  • Mailing address is C/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA 19355 PA

What are Aclaris Therapeutics, Inc's Past Insider Trades?

Aclaris Therapeutics, Inc's most recent insider trade came on November 14, 2022 by Andrew Schiff who sold 53,926 units worth $919.59K . In the last 7 years, insiders at Aclaris Therapeutics, Inc have sold an estimated value of $94.33M and bought an estimated value of $61.5M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Kamil Alijackson, Chief Legal Officer,  Frank Ruffo, Chief Financial Officer,  and Neal Walker, President and CEO .

Aclaris Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1